Emosis raises another 1 million Euros from Cap Innov’Est
June 26th , 2018
Few days after initiating its commercial operations, Emosis raises another 1 million Euros from Cap Innov’Est, to fuel growth and innovation
Emosis announces an exclusive distribution agreement with 5-Diagnostics
Strasbourg and Basel, June 12th, 2018
Emosis announces an exclusive distribution agreement with 5-Diagnostics and the start of commercialization.
The company starts selling its first test, HIT Confirm®, through 5-Diagnostics’ international network.
EMOSIS announces CE Mark approval for HIT Confirm® kit
Strasbourg, France –March 20th, 2018
Emosis, a young medical device company specializing in cell-based hemostasis diagnostics, is thrilled to announce that the company recently CE-marked its first kit, the Emo-test HIT Confirm®. The company is about to start marketing its first in vitro diagnostic kit in cell-based Hemostasis